OMOP Concept 1970415
buprenorphine 2 MG / naloxone 0.5 MG Oral Tablet
StandardDrugRxNorm ExtensionOMOP5163003Clinical Drug
Maps from
0
Descendants
3
Valid from
28 Jan 2022
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(21)Roll up to these when you need a wider cohort.
- 1buprenorphine 2 MG
- 1buprenorphine / naloxone Oral Tablet
- 1naloxone 0.5 MG
- 2buprenorphine
- 2buprenorphine, combinations; sublingual
- 2buprenorphine; implant, parenteral, sublingual
- 2naloxone
- 2naloxone
- 2naloxone
- 3Antidotes
- 3Drugs used in opioid dependence
- 3Peripheral opioid receptor antagonists
- 4ALL OTHER THERAPEUTIC PRODUCTS
- 4DRUGS FOR CONSTIPATION
- 4DRUGS USED IN ADDICTIVE DISORDERS
- 5ALL OTHER THERAPEUTIC PRODUCTS
- 5DRUGS FOR CONSTIPATION
- 5OTHER NERVOUS SYSTEM DRUGS
- 6ALIMENTARY TRACT AND METABOLISM
- 6NERVOUS SYSTEM
- 6VARIOUS
Narrower concepts
(3)Included automatically when you query with descendants.
Get this concept via the API
Resolve buprenorphine 2 MG / naloxone 0.5 MG Oral Tablet - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/1970415?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card